1. Home
  2. NRXP vs MLGO Comparison

NRXP vs MLGO Comparison

Compare NRXP & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • MLGO
  • Stock Information
  • Founded
  • NRXP 2015
  • MLGO 2018
  • Country
  • NRXP United States
  • MLGO China
  • Employees
  • NRXP N/A
  • MLGO N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • MLGO EDP Services
  • Sector
  • NRXP Health Care
  • MLGO Technology
  • Exchange
  • NRXP Nasdaq
  • MLGO Nasdaq
  • Market Cap
  • NRXP 32.6M
  • MLGO 32.4M
  • IPO Year
  • NRXP N/A
  • MLGO N/A
  • Fundamental
  • Price
  • NRXP $2.93
  • MLGO $1.15
  • Analyst Decision
  • NRXP Strong Buy
  • MLGO
  • Analyst Count
  • NRXP 4
  • MLGO 0
  • Target Price
  • NRXP $28.50
  • MLGO N/A
  • AVG Volume (30 Days)
  • NRXP 378.9K
  • MLGO 46.2M
  • Earning Date
  • NRXP 05-15-2025
  • MLGO 04-28-2025
  • Dividend Yield
  • NRXP N/A
  • MLGO N/A
  • EPS Growth
  • NRXP N/A
  • MLGO N/A
  • EPS
  • NRXP N/A
  • MLGO 0.55
  • Revenue
  • NRXP N/A
  • MLGO $74,185,505.00
  • Revenue This Year
  • NRXP N/A
  • MLGO N/A
  • Revenue Next Year
  • NRXP N/A
  • MLGO N/A
  • P/E Ratio
  • NRXP N/A
  • MLGO $2.34
  • Revenue Growth
  • NRXP N/A
  • MLGO N/A
  • 52 Week Low
  • NRXP $1.10
  • MLGO $1.11
  • 52 Week High
  • NRXP $6.01
  • MLGO $509.60
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 66.47
  • MLGO 33.39
  • Support Level
  • NRXP $2.55
  • MLGO $1.17
  • Resistance Level
  • NRXP $2.72
  • MLGO $1.75
  • Average True Range (ATR)
  • NRXP 0.24
  • MLGO 0.37
  • MACD
  • NRXP 0.02
  • MLGO 0.27
  • Stochastic Oscillator
  • NRXP 80.00
  • MLGO 1.24

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

Share on Social Networks: